1Huppertz B, Kingdom J, Caniggia I et al. Hypoxia favours necrotic versus apoptotie shedding of placental syncytiotrophoblast into the maternal circulation [J].Placenta, 2003, 24 (2 -3) : 181.
2Kanai T, Fujii T, Kozurna Set al. Soluble HLA-G influences the release of cytokines from allogeneic peripheral - blood mononuclear cells in culture [J] . Mol Hum Repred, 2001, 7 (2) : 195.
4Contini P, Ghio M, Poggi A et al. Soluble HLA-A, -B -C and - G molecules induce apoptosis in T and NK CD8 ceils and inhibit cytotoxic T cell activity through CD8 ligatian [ J ] . Immunol, 2002, 33 (1): 125.
5Abrahams VM, Straszewski - Chavez SL, Guller S et al. First trimester trophoblast cells secret Fas ligand which induced immune cell apoptosis [J] . Mol Hum Reprod, 2004, 10 (1) : 55.
8Zenclussen AC, Gerlof K, Zenclussen ML et al. Abnormal T - Cell reactivity against paternal antigens in spontaneous abortion: adoptivetransfer of pregnancy - induced CD4^+ CD25^ + T regulatory cells prevents fetal rejection in a murine abortion model [ J ] . Am J Pathol, 2005, 166:811.
4Stephens LA, Mottet C, Mason D, et al. Human CIM ( + ) CD25 ( + ) thymocytes and peripheral T cells have immune suppressive activity in vitro[J]. Eur J Immunol,2001,31 (4) :1247 -54.
5Aluvihare VR, Kallikourdis M, Betz AG. Tolerance, suppression and the fetal allograft[ J]. J Mol Med,2005,83(2) :88 -96.
6Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3 [ J ]. Science, 2003,299 (5609) : 1057 - 61.
7Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4 + CD25 + regulatory T cells [J]. Nat Immunol,2003,4 (4) :330 - 6.
8Tumbo- Oeri AG, Omwandho CA, Muchirl JM. Possible immunological basis for recurrent spontaneous abortions: a review [ J] . East Mr Med J ,2001,78 (11 ) :586 -9.
9Paust S, Cantor H. Regulatory T cells and autoimmune disease [ J ]. Immunol Rev,2005,204 : 195 - 207 .
10Somerset DA, Zheng Y, Kilby MD, et al. Normal human pregnancy is associated with an elevation in the immune suppressive CD25 + CD4 + regulatory T - cell subset [ J ]. Immunology,2004,112 ( 1 ) : 38 -43.
6NGUYEN G, GARCIA RT, NGUYEN N, et al. Clinical course of hepatitis B virus infection during pregnancy [ J ]. Aliment Pharmacol Ther, 2009, 29(7). 755-764.
7PAN CQ, ZOU HB, CHEN Y, et al. Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen - positive women to their infants [ J ]. Clin Gastroenterol Hepatol, 2013, 11 (10) : 1349 - 1355.
8SHAO Z J, ZHANG L, XU JQ, et al. Mother - to - infant transmission of hepatitis B virus, a Chinese experience [ J ]. J Med Virol, 2011, 83(5) : 791 -795.
9PAN CQ, LEE HM. Antiviral therapy for chronic hepatitis B in pregnancy[J]. Semin Liver Dis, 2013, 33(2) 138 -146.
10HAN GR, CAO MK, ZHAO W, et al. A prospective and open - label study for the efficacy and safety of telbivudine in pregnan- cy for the prevention of perinatal transmission of hepatitis B vi- rus infection[J]. J Hepatol, 2011,55(6) : 1215 -1221.
